Silver Book Fact

Assuming that Medicare Part D covers about 37% of beneficiaries’ drug costs, it is estimated that providing post-myocardial infarction Medicare beneficiaries with full coverage for combination pharmcotherapy will save more than $5,600 per patient over a 3-year period.

Choudhry N, Avorn J, Antman E, Schneeweiss S, et al. Should Patients Receive Secondary Prevention Medications For Free After A Myocardial Infarction? An economic analysis. Health Affairs. 2007; 26(1): 186-194. https://www.healthaffairs.org/doi/abs/10.1377/hlthaff.26.1.186?url_ver=Z39.88-2003&rfr_id=ori%3Arid%3Acrossref.org&rfr_dat=cr_pub%3Dpubmed

Reference

Title
Should Patients Receive Secondary Prevention Medications For Free After A Myocardial Infarction? An economic analysis
Publication
Health Affairs
Publisher
Project HOPE
Publication Date
2007
Authors
Choudhry N, Avorn J, Antman E, Schneeweiss S, et al.
Volume & Issue
Volume 26, Issue 1
Pages
186-194
URL
Read Full Resource

Categories

  • Innovative Medical Research
  • Economic Value

Related Facts

  • Over 1 million angioplasty-stent procedures are estimated to be performed each year in the U.S.  
  • Hospitalization from incorrect diagnosis of heart attacks costs $12 billion per year. If creatine kinase, myoglobin and troponin are used for detecting heart attack in ER patients with chest pain,…  
  • Life expectancy and quality of life gains from AVR
    A study of 4,617 patients who underwent aortic valve replacement (AVR) over a period of 20 years found significant gains in life expectancy and quality of life — 43,166 net life-years…  
  • Patients Taking Medicines for Heart Failure Incur Lower Health Care Costs: Beta-blockers reduce total treatment costs for heart failure by $3,959  
  • From approval in 2011 through 2015 >54,000 TAVRs were performed in 418 centers in 48 states